Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

COVID-19 nucleic acid testing primer probe composition, COVID-19 nucleic acid testing kit and COVID-19 nucleic acid testing method

A detection kit and technology for coronavirus, applied in the fields of biotechnology and medical testing, can solve the problems of mutual interference of detection probes, low sensitivity and low accuracy, and achieve the effect of high accuracy, high sensitivity and avoiding false negatives

Pending Publication Date: 2020-09-04
SHANGHAI CHROMYSKY MEDICAL RES +1
View PDF3 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In order to overcome the problems of low accuracy, poor specificity and low sensitivity of traditional virus nucleic acid detection methods, the present invention provides a novel coronavirus nucleic acid detection primer probe composition with high accuracy, good specificity and high sensitivity, which avoids multiple The mutual interference between each primer pair and the corresponding detection probe

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • COVID-19 nucleic acid testing primer probe composition, COVID-19 nucleic acid testing kit and COVID-19 nucleic acid testing method
  • COVID-19 nucleic acid testing primer probe composition, COVID-19 nucleic acid testing kit and COVID-19 nucleic acid testing method
  • COVID-19 nucleic acid testing primer probe composition, COVID-19 nucleic acid testing kit and COVID-19 nucleic acid testing method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0047] The technical solutions of the present invention will be further specifically described below through specific embodiments and in conjunction with the accompanying drawings.

[0048] In the present invention, unless otherwise specified, all equipment and raw materials can be purchased from the market or commonly used in this industry. The methods in the following examples, unless otherwise specified, are conventional methods in this field.

[0049] In order to ensure the accuracy of the detection results of the new coronavirus, two genes in the virus genome, SEQ ID No10 and SEQ ID No11, were selected as target sequences, and specific primer probes (SEQ ID No.1-6) were designed for amplification to detect human genome There is no fluorescent amplification signal in DNA or other pathogenic genomes, but there are fluorescent amplification signals in the detection of novel coronavirus genomes.

[0050] In order to eliminate false negatives, false positives, contamination an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of the biological technology and the medical examination technology, and provides a COVID-19 nucleic acid testing primer probe composition, a COVID-19 nucleic acid testing kit and a COVID-19 nucleic acid testing method for solving the problems of low accuracy, poor specificity and low sensitivity of a traditional virus nucleic acid testing method. The COVID-19 nucleic acid testing primer probe composition comprises a first primer probe group, a second primer probe group and a third primer probe group, wherein the first primer probe group comprises a forward primer ORF1ab-F, a probe ORF1ab-P and a reverse primer ORF1ab-R; the second primer probe group comprises a forward primer N-F, a probe N-P and a reverse primer N-R; and the third primer probe group comprises a forward primer Rpp30-F, a probe Rpp30-P and a reverse primer Rpp30-R. According to the primer probe composition disclosed by the invention, through artful design of an amplification primer pair and a detection probe, mutual interference between a plurality of primer pairs and corresponding detection probes is avoided. The kit has a simple structure, an interior label is used for monitoring a collection, transportation and extraction process of a sample to be detected, and the false negative of a detection result is avoided.

Description

technical field [0001] The invention relates to the technical fields of biotechnology and medical testing, in particular to a novel coronavirus nucleic acid detection primer probe composition, kit and method. Background technique [0002] The new coronavirus (COVID-19) is a positive-sense single-stranded RNA coronavirus with an envelope. The length of each genome of this virus is about 30,000 nucleotides, and it belongs to the coronavirus lineage B (BetacoronavirusLineage B , Sarbecovirus). Similar to SARS-CoV, COVID-19 can be bound by human ACE2 as a receptor, enter the lungs through respiratory epithelial cells for replication, and the main target is the same T lymphocytes as SARS-CoV. It is mainly transmitted through unprotected close contact with infected people and droplets, and may also be transmitted through aerosols. The basic clinical symptoms are fever, dry cough, and fatigue. A small number of patients have symptoms such as nasal congestion, runny nose, sore th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/70C12Q1/6851C12N15/11
CPCC12Q1/701C12Q1/6851C12Q2600/166C12Q2531/113C12Q2521/107C12Q2563/107C12Q2545/101C12Q2545/113Y02A50/30
Inventor 方耀东陈林李明阳韩丽张文学古迪
Owner SHANGHAI CHROMYSKY MEDICAL RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products